SYNDAX PHARMACEUTICALS INC

Profile

Company Names

SYNDAX PHARMACEUTICALS INC

Addresses

400 TOTTEN POND ROAD, SUITE 110, WALTHAM, MA 02451

400 TOTTEN POND ROAD, SUITE 140, WALTHAM, MA 02451

460 TOTTEN POND ROAD, SUITE 650, WALTHAM, MA 02451

Phone Numbers

781-419-1400

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2005

State Incorporated:

DELAWARE

Total Amount Raised:

$139,546,528.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2015-08-21 
$61,252,462.00 
$61,252,462.00 
$0.00 
Equity 
8
2015-06-01 
$23,961,064.00 
$45,211,064.00 
$21,250,000.00 
Equity 
7
2014-09-18 
$4,947,480.00 
$5,000,000.00 
$52,520.00 
Debt 
6
2014-02-04 
$1,728,471.00 
$1,728,471.00 
$0.00 
 
5
2014-01-23 
$1,270,093.00 
$1,270,093.00 
$0.00 
 
4
2013-11-13 
$50,000.00 
$50,000.00 
$0.00 
Equity 
3
2013-03-08 
$31,330,958.00 
$48,411,733.00 
$17,080,775.00 
Equity 
2
2010-08-03 
$6,006,000.00 
$7,007,000.00 
$1,001,000.00 
Debt 
1
2010-01-22 
$9,000,000.00 
$16,000,000.00 
$7,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
HENRY 
 
CHEN 
DIRECTOR
SYNDAX PHARMACEUTICALS INC   |  APAMA MEDICAL, INC.   |  STROKE PROJECT, INC.   |  ATIA VISION, INC.   |  TULAVI THERAPEUTICS, INC.   |  CURAMIR THERAPEUTICS, INC.   |  IMPERATIVE CARE, INC.   |  TRIBORO ADMINISTRATIVE SERVICES HOLDINGS, LLC   |  EXSILIO THERAPEUTICS INC.   |  AVERNA THERAPEUTICS INC.   |  INSTYLLA, INC.
FABRICE 
 
EGROS 
DIRECTOR
SYNDAX PHARMACEUTICALS INC
FABRICE 
 
EGROS, PH.D. 
DIRECTOR
SYNDAX PHARMACEUTICALS INC
LUKE 
 
EVNIN, PH.D. 
DIRECTOR
NEUROTHERAPEUTICS PHARMA, INC.   |  SYNDAX PHARMACEUTICALS INC
ROBERT 
 
GOODENOW, PH.D. 
EXECUTIVE OFFICER
SYNDAX PHARMACEUTICALS INC
ROBERT 
 
GOODENOW, PHD 
EXECUTIVE OFFICER
SYNDAX PHARMACEUTICALS INC
JOANNA 
 
HOROBIN, M.D. 
DIRECTOR, EXECUTIVE OFFICER
SYNDAX PHARMACEUTICALS INC
KIM 
 
KAMDAR, PH.D 
DIRECTOR
SYNDAX PHARMACEUTICALS INC
KIM 
 
KAMDAR, PH.D. 
DIRECTOR
SYNDAX PHARMACEUTICALS INC   |  SALVEO DX, INC.   |  OBALON THERAPEUTICS INC   |  OMNIOME, INC.
KIM 
 
KAMDAR, PHD 
DIRECTOR
SYNDAX PHARMACEUTICALS INC
ROSINA 
 
MAAR PAVIA, M.D. 
DIRECTOR
SYNDAX PHARMACEUTICALS INC
MICHAEL 
 
METZGER 
EXECUTIVE OFFICER
PAYSCALE INC   |  MERSANA THERAPEUTICS INC   |  REGADO BIOSCIENCES INC   |  PAYSCALE HOLDINGS, INC.   |  SYNDAX PHARMACEUTICALS INC   |  TARVEDA THERAPEUTICS, INC.   |  HEADSET, INC.
ARLENE 
 
MORRIS 
EXECUTIVE OFFICER, DIRECTOR
AFFYMAX INC   |  NUON THERAPEUTICS INC   |  SYNDAX PHARMACEUTICALS INC   |  VIVEVE MEDICAL, INC.   |  UNUM THERAPEUTICS INC.   |  TC BIOPHARM (HOLDINGS) PLC
BRIGGS 
 
MORRISON, M.D. 
EXECUTIVE OFFICER, DIRECTOR
SYNDAX PHARMACEUTICALS INC
JOHN 
 
PALLIES 
EXECUTIVE OFFICER
SYNDAX PHARMACEUTICALS INC
DENNIS 
 
PODLESAK 
DIRECTOR
CORTHERA INC   |  REGADO BIOSCIENCES INC   |  SYNDAX PHARMACEUTICALS INC   |  ADYNXX INC   |  KALIDEX PHARMACEUTICALS, INC.   |  RIGHTCARE SOLUTIONS, INC.   |  ADYNXX, INC.   |  ADASTRA PHARMACEUTICALS, INC.   |  EXALYS THERAPEUTICS, INC.   |  TRANSPOSON THERAPEUTICS, INC.
IVOR 
 
ROYSTON 
DIRECTOR
TARGEGEN INC   |  ALTAIR THERAPEUTICS, INC.   |  HEMAQUEST PHARMACEUTICALS   |  LIGOCYTE PHARMACEUTICALS INC   |  BIOCEPT INC   |  HEMAQUEST PHARMACEUTICALS, INC.   |  SYNDAX PHARMACEUTICALS INC   |  VIRACTA THERAPEUTICS, INC.   |  VIRACTA SUBSIDIARY, INC.   |  LIONS MATE WITH LIONS, LTD LIABILITY CO
IVOR 
 
ROYSTON, M.D. 
DIRECTOR
LIGOCYTE PHARMACEUTICALS INC   |  SYNDAX PHARMACEUTICALS INC
RICHARD 
P 
SHEA 
DIRECTOR
SYNDAX PHARMACEUTICALS INC
GEORGE 
W 
SLEDGE, JR. M.D. 
DIRECTOR
SYNDAX PHARMACEUTICALS INC
GEORGE 
W 
SLEDGE, JR., M.D. 
DIRECTOR
SYNDAX PHARMACEUTICALS INC
STEVEN 
 
ST. PETER, M.D. 
DIRECTOR
SYNDAX PHARMACEUTICALS INC   |  ARATANA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-08-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-08-21 
2015-06-15
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-06-01 
2014-09-19
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2014-09-18 
2014-02-13
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2014-01-23 
2014-02-13
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2014-02-04 
2013-11-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-11-13 
2013-08-30
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-08 
2010-08-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2010-08-03 
2010-02-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-01-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#